We believe that if people know more about the world’s creatures they will better care for them. That’s why we add new animals for you to discover – each and every day! Learn about any animal using the ...
Shares of bluebird bio (NASDAQ:BLUE) continued their downward descent Monday in the wake of news that the company has agreed to be taken private by Carlyle Group (NASDAQ:CG) and SK Capital ...
Today’s game against the Tigers has been cancelled due to inclement weather.Looks like it’s going to be raining pretty much all day in Lakeland, so they’ve decided to just get in front of it ...
In the race to develop satellite services, AT&T and Verizon are both hailing recent tests that show they can power video calls on US phones using next-gen satellites from AST SpaceMobile. The ...
Fast-forward to the present. On Friday, the Supreme Court decided Williams v. Reed. On the holding, the Court split 5-4. Justice Kavanuagh's majority opinion held that state courts must allow a ...
Bluebird Bio (NASDAQ: BLUE) said its planned acquisition by two investment firms is, according to its board, “in the best interest of stockholders”—but enough of them felt otherwise on ...
Ms. Reid’s 7 p.m. program will be replaced by a panel show co-hosted by Symone Sanders Townsend, Alicia Menendez and Michael Steele. By Benjamin Mullin Joy Reid’s evening news show on MSNBC is ...
Irish authorities “were alerted to the discovery of partial human remains” on Feb. 21, per a police statement obtained by PEOPLE Toria Sheffield joined the PEOPLE editorial staff in 2024. Her ...
Jim Whitmore formerly owned Ruban’s and Toto in Newcastle, and after a period working as a mixologist in London, he has now decided to return home and open The Bluebird, on Kingsway in Stoke.
(CNN) – The U.S. Department of Agriculture issued a conditional license for an avian flu vaccine. It would be used in chickens, amid an outbreak ravaging poultry flocks, contributing to the risi ...
Cash-strapped gene-therapy company Bluebird bio agreed to be acquired by private-equity firms Carlyle Group and SK Capital Partners in a deal potentially worth up to $96 million. Bluebird on ...
A pair of in­vestors will ac­quire blue­bird bio in a deal worth on­ly $29 mil­lion up­front af­ter the gene ther­a­py mak­er ran out of time … ...